Recombinant Human GTP cyclohydrolase 1 (GCH1)

Code CSB-YP009317HU
MSDS
Size Pls inquire
Source Yeast
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP009317HU
MSDS
Size Pls inquire
Source E.coli
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-EP009317HU-B
MSDS
Size Pls inquire
Source E.coli
Conjugate Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-BP009317HU
MSDS
Size Pls inquire
Source Baculovirus
Have Questions? Leave a Message or Start an on-line Chat
Code CSB-MP009317HU
MSDS
Size Pls inquire
Source Mammalian cell
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>85% (SDS-PAGE)
Target Names
GCH1
Uniprot No.
Alternative Names
dystonia 14; DYT 5; DYT14; DYT5; DYT5a; GCH 1; GCH; Gch1; GCH1_HUMAN; GTP CH 1; GTP CH I ; GTP cyclohydrolase 1 (dopa responsive dystonia); GTP cyclohydrolase 1; GTP cyclohydrolase I; GTP-CH-I; GTPCH 1; GTPCH1; Guanosine 5' triphosphate cyclohydrolase I; HPABH4B
Species
Homo sapiens (Human)
Expression Region
1-250
Target Protein Sequence
MEKGPVRAPA EKPRGARCSN GFPERDPPRP GPSRPAEKPP RPEAKSAQPA DGWKGERPRS EEDNELNLPN LAAAYSSILS SLGENPQRQG LLKTPWRAAS AMQFFTKGYQ ETISDVLNDA IFDEDHDEMV IVKDIDMFSM CEHHLVPFVG KVHIGYLPNK QVLGLSKLAR IVEIYSRRLQ VQERLTKQIA VAITEALRPA GVGVVVEATH MCMVMRGVQK MNSKTVTSTM LGVFREDPKT REEFLTLIRS
Protein Length
Full length protein
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
Form
Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer before Lyophilization
Tris/PBS-based buffer, 6% Trehalose, pH 8.0
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet
Please contact us to get it.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown.
Gene References into Functions
  1. Study identified 15 patients with GCH1 mutations (15 patients from seven families and five sporadic cases). The patients presented two distinctive phenotypes of juvenile or young-onset dopa-responsive dystonia and Parkinson's disease, which clinically and radiologically shared characteristic features. GCH1 mutations induce the distinctive symptoms among young or middle age at onset. PMID: 29948246
  2. It is a genetic risk for Parkinson's disease. PMID: 29724574
  3. One novel mutation of c.679A>G (p.T227A) in GCH1 and 3 known mutations of c.457C>T (p.R153X), c.739G>A (p.G247S), and c.698G>A (p.R227H) in tyrosine hydroxylase (TH) have been found and predicted to be damaging or deleterious. PMID: 29405179
  4. Our data expand the genotypic spectrum of GCH1 and confirm the broad phenotypic spectrum of GTP cyclohydrolase 1-deficient DOPA-responsive dystonia in the Serbian population PMID: 28958832
  5. Our results suggest that rs329648 is associated with risk of developing PD in the Han Chinese population. Our findings should be verified in further studies, and they highlight the need for functional studies of MIR4697. PMID: 28380328
  6. Association analysis indicated that the Tibetan version of GCH1 was significantly associated with multiple physiological traits in Tibetans, including blood nitric oxide concentration, blood oxygen saturation, and hemoglobin concentration. PMID: 28585439
  7. This study indicates that mutations in GCH1 are rare in late-onset Parkinson disease. PMID: 27185167
  8. This study shown GCH1 genetic variants for Parkinson's disease are associated with the risk of incident Parkinson's disease in the general population and with impairment in daily functioning in individuals without clinical parkinsonism. PMID: 27269966
  9. GCH1 variants affect early PD risk through altered dopamine uptake, and aging alters how genetic factors contribute to disease development. PMID: 27871051
  10. c.550C>T mutation is associated with dopa-responsive dystonia. PMID: 28397219
  11. This study demonstrated that whole-exome sequencing show reveled GCH1 mutation with early-onset generalized dystonia. PMID: 27666935
  12. Deletion of GCH1 likely contributes to dopa-responsive dystonia. PMID: 28558098
  13. High GCH1 expression is associated with esophageal squamous cell carcinoma. PMID: 27826622
  14. Dopa-responsive dystonia phenotype may have heterogeneous genetic background and may be caused by point mutations or rearrangements in the GCH1 gene as well as in the PARK2 gene. PMID: 27667361
  15. This study found that rs11158026 (GCH1) is associated with Parkinson disease in Iran population. PMID: 27653855
  16. No association between the GCH1 pain-protective haplotype and cervical dilation was found, but a previously demonstrated association with increased use of second-line analgesia was confirmed. PMID: 26392364
  17. GTPCH/Ang-1 interaction in stromal fibroblasts and activation of Tie2 on breast tumor cells could play an important role in supporting breast cancer growth. GTPCH may be an important mechanism of paracrine tumor growth and hence a target for therapy in breast cancer. PMID: 26814432
  18. suggest that the GCH1 and MIR4697 but not SIPA1L2 and VPS13C are genetic loci influencing risk of Parkinson's disease in Taiwan PMID: 26804608
  19. The risk of orofacial clefts is associated with variants of the GCH1 gene related to BH4 metabolism. PMID: 26215833
  20. Exonic deletion in the GCH1 gene only accounted for the etiology in a small percentage of patients with sporadic dopa-responsive dystonia in our Han Chinese cohort. PMID: 26400349
  21. identified a novel missense variant, c.5A > G, p.(Glu2Gly), within the GCH1 gene in affected family members displaying a range of phenotypes; variant is pathogenic in studied family and may underlie Parkinson's disease and Dopa-responsive dystonia PMID: 25634433
  22. No association was seen between the pain protective GCH-1 haplotype and the development of hypersensitivity following injury. An increase in baseline pain thresholds was seen between visits in protective haplotype carriers who sensitized to injury. PMID: 25783971
  23. Postherniotomy pain and related activity impairment was associated with functional variations in GCH1 (and COMT). PMID: 25599448
  24. This is the first study to report changes in the expression of GTP Cyclohydrolase I of this gene in schizophrenia. PMID: 25270546
  25. Five polymorphisms forming two haplotype blocks within the GTP cyclohydrolase 1 gene are associated with endothelial dysfunction and oxidative stress. PMID: 25369080
  26. DYT5 is caused by heterozygous mutations of the GCH1 gene, located on 14q22.1-q22.2[review] PMID: 25192508
  27. This study supports to the conclusions that susceptibility to idiopathic dystonia is not greatly affected by common genetic variants of GCH1 polynorphisms. PMID: 24674769
  28. alterations in GCH1 activity affect attentional function, especially sustained attention and vigilance. PMID: 24561090
  29. Elevated phenylalanine and phenylalanine:tyrosine ratio in the blood of schizophrenia patients which may be a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality. PMID: 24465804
  30. Rare GCH1 variants are associated with an increased risk for Parkinson's disease. PMID: 24993959
  31. A novel GCH1 gene frameshifing mutation is aooociated with the dopa-responsive dystonia in a Chinese family. PMID: 25119902
  32. Clinical features and genetic testing results of GCH1 from 19 patients that included 4 families who have been followed-up for up to 25 years were analyzed. PMID: 24018121
  33. This is the first GCH1 regulatory substitution reported to act at a post-transcriptional level, increasing the list of genetic diseases caused by abnormal translation PMID: 24124602
  34. The presence of a GCH1 haplotype with high BH4 in populations of African ancestry could explain the association of rs8007267 with sickle cell anemia pain crises. PMID: 24136375
  35. Current known dystonia genes include those related to dopamine metabolism, transcription factor, cytoskeleton, transport of glucose and sodium ion, etc. PMID: 23782819
  36. Three novel GTP cyclohydrolase I mutations were identified in familial and sporadic dopa-responsive dystonia patients. PMID: 23762320
  37. Most GCH1 mutations were found to cluster in two regions of the coding sequence, suggesting the probable existence of mutation hotspot for the first time. PMID: 23211702
  38. Our study provides evidence that certain GCH1 haplotypes may be protective against susceptibility and pain sensitivity in FM. PMID: 23322459
  39. Results suggest that GCH1 may predict response to serotonin selective reuptake inhibitors in major depressive disorder in the Japanese population. PMID: 22770721
  40. No SNPs or haplotypes in GCH1 were associated with pain intensity in a black southern African population with HIV-associated sensory neuropathy. PMID: 23314412
  41. This study reveled that Three novel mutations in GCH1 gene have been found and are shown to be associated with variable clinical phenotypes mostly within the spectrum of dopa responsive dystonia. PMID: 22373569
  42. The GCH1 3'-UTR C+243T variant was an independent predictor of worsening long-term outcomes in patients with first-onset ischemic stroke. PMID: 21181356
  43. Offspring and maternal variation in the GCH1 gene and altered tetrahydrobiopterin biosynthesis may contribute to neural tube defects risk. PMID: 23059057
  44. GTPCH1 non-covalently interacts with polyubiquitin via an ubiquitin-binding domain. PMID: 22984419
  45. The results of this study identificated and charactered of a novel 24-kb deletion spanning exon 1 and the 5' regulatory region of GCH1 causing a wide spectrum of motor and nonmotor symptoms in a large Belgian dopa-responsive dystonia family. PMID: 22976901
  46. The results of this study gave no support to the hypothesis that polymorphism in the GCH1-gene contributes to the etiology of provoked vestibulodynia . PMID: 22971341
  47. Data indicate that myocardial nitric oxide synthase 1 (NOS1) activity was increased in GCH1 transgenic mice (mGCH1-Tg). PMID: 22798524
  48. This study found that Modest genotypic associations (P<0.05) were observed for three GCH1 SNPs (rs12147422, rs3759664 and rs10483639) when comparing all cases against controls. PMID: 22172551
  49. this study reported that 2 children with dopa-responsive dystonia with GTP-cyclohydrolase 1 mutations. PMID: 22068827
  50. Subsequently, the role of GTP cyclohydrolase 1 in painful HIV-associated sensory neuropathy remains possible. PMID: 22293547

Show More

Hide All

Involvement in disease
Hyperphenylalaninemia, BH4-deficient, B (HPABH4B); Dystonia, dopa-responsive (DRD)
Subcellular Location
Cytoplasm. Nucleus.
Protein Families
GTP cyclohydrolase I family
Tissue Specificity
In epidermis, expressed predominantly in basal undifferentiated keratinocytes and in some but not all melanocytes (at protein level).
Database Links

HGNC: 4193

OMIM: 128230

KEGG: hsa:2643

STRING: 9606.ENSP00000378890

UniGene: Hs.86724

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1